Abnormal oral mucosal light reflectance: a new clinical marker of high risk for colorectal cancer

de Felice, C.; Gentile, M.; Barducci, A.; Bellosi, A.; Parrini, S.; Chitano, G.; Latini, G.
October 2006
Gut;Oct2006, Vol. 55 Issue 10, p1436
Academic Journal
Background: A familial predisposition to colorectal cancer (CRC) has been clearly established, consisting of familial clustering in 15-20% and clear hereditary aetiology in 5–10% of overall CRC cases. Early identification of families and individuals at high risk is essential as intensive surveillance has been demonstrated to reduce cancer incidence and overall mortality. In the present study, the value of oral mucosal light reflectance in identifying hereditary non-polyposis colorectal cancer (HNPCC) carriers was investigated. Methods: Twenty members of six different genetically unrelated HNPCC kindred and 30 genetically unrelated age and sex matched healthy controls were examined. Lower gingival and vestibular oral mucosal reflectance was measured using an imaging spectrophotometer. Results: HNPCC carriers showed significantly lower values in the 590–700 nm wavelength range (p ⩽ 0.0004). A reflectance cut off value ⩽47.9% at the 700 nm wavelength discriminated between HNPCC carriers and controls, with 100% sensitivity and 100% specificity. Conclusions: These findings may provide an additional phenotypic sign in HNPCC carriers, which could be used in first level CRC population screening programmes.


Related Articles

  • Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Cao, Yangming; Pieretti, Maura; Marshall, Jay; Khattar, Nada H.; Chen, Bifen; Kam-Morgan, Lauren; Lynch, Henry // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1822 

    The clinical differentiation between hereditary nonpolyposis colorectal cancer (HNPCC) and attenuated familial adenomatous polyposis (AFAP) is very difficult. The 62-yr-old proband presented with duodenal adenocarcinoma. His history of subtotal colectomy for colon cancer, the rarity of duodenal...

  • In The News: UK approves screening embryos for cancer. Childs, Oliver // Nature Reviews Cancer;Dec2004, Vol. 4 Issue 12, p926 

    Reports that the British fertility watchdog, the Human Fertilisation and Embryology Authority, has granted University College Hospital London a license to screen embryos for the gene that causes familial adenomatous polyposis (FAP). Predisposition of FAP to colorectal cancer; Possible licenses...

  • A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Iwama, Takeo; Tamura, Kazuo; Morita, Takayuki; Hirai, Takashi; Hasegawa, Hirotoshi; Koizumi, Koichi; Shirouzu, Kazuo; Sugihara, Kenichi; Yamamura, Takehira; Muto, Tetsuichiro; Utsunomiya, Joji // International Journal of Clinical Oncology;Aug2004, Vol. 9 Issue 4, p308 

    The clinical situation of familial adenomatous polyposis (FAP) in Japan has changed in the period since the last analysis of data of the Japanese Polyposis Center. To reevaluate our data and elucidate the changes we analyzed the records of the 1390 FAP patients in 900 families registered with...

  • APC Gene Testing for Familial Adenomatosis Polyposis. Roy, Hemant K.; Khandekar, Janardan D. // JAMA: Journal of the American Medical Association;8/1/2012, Vol. 308 Issue 5, p514 

    The authors reflect on the beneficial effects of genomics in the diagnosis of familial adenomatosis polyposis. He informs that commercial assays for adenomatous polyposis coli (APC) and mutY homologue (MUTYH) gene has fostered rapid implementation of these scientific advances into clinical...

  • Prolactin-Secreting Pituitary Adenomas in Multiple Endocrine Adenomatosis, Type I. Prosser, Peterman R.; Karam, John H.; Townsend, Jeannette J.; Forsham, Peter H. // Annals of Internal Medicine;Jul79, Vol. 91 Issue 1, p41 

    Presents case reports on the occurrence of prolactin-secreting pituitary adenomas in patients with multiple endocrine adenomatosis type 1. Case reports; Measurement of the frequency of hyperprolactinemia in patients with multiple endocrine adenomatosis; Results of physical examination.

  • Natural History of Ampullary Adenoma in Familial Adenomatous Polyposis: Reconfirmation of Benign Nature During Extended Surveillance. Matsumoto, Takayuki; Iida, Mitsuo; Nakamura, Shotaro; Hizawa, Kazuoki; Yao, Takashi; Tsuneyoshi, Masazumi; Fujishima, Masatoshi // American Journal of Gastroenterology;Jun2000, Vol. 95 Issue 6, p1557 

    OBJECTIVE: Surgical or endoscopic papillectomy may be one of the therapeutic strategies for patients with familial adenomatous polyposis (FAP). To determine whether prophylactic papillectomy is necessary for FAP, we investigated the natural history of the ampullary adenoma in FAP. METHODS:...

  • Hypergastrinemia in Familial Multiple Endocrine Adenomatosis. Snyder, Ned; Scurry, Murphy; Hughes, William // Annals of Internal Medicine;Mar74, Vol. 80 Issue 3, p321 

    Presents a study which examined hypergastrinemia in families with familial multiple endocrine adenomatosis. Etiology of the disease; Overview of clinical and laboratory characteristics of family members involved in the study; Association between hypergastrinemia and hyperparathyroidism.

  • ISN'T IT TIME TO RETHINK FAMILIAL ADENOMATOUS POLYPOSIS? Schussheim, Arnold; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Jul1994, Vol. 89 Issue 7, p1116 

    Discusses an article about several members of a family that were diagnosed as having familial adenomatous polyposis (FAP). Marker for the FAP gene; Factor which can be used for premorbid diagnosis and counseling of FAP families; Suggestion for children born into families where hepatoblastoma or...

  • Multiple Endocrine Neoplasia 1: Providing Care for the Family. Mahon, Suzanne M.; Waldman, Laura // Clinical Journal of Oncology Nursing;Oct2010, Vol. 14 Issue 5, p657 

    Multiple endocrine neoplasia 1 (MEN1) is a hereditary syndrome associated with a number of endocrine and nonendocrine tumors. Unfortunately, a diagnosis of MEN1 often is delayed until after the patient has developed an advanced or second MEN1-related tumor. Nurses need to be familiar with...


Read the Article


Sign out of this library

Other Topics